Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive (Loss) Gain	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022		133,236,687
Beginning balance at Dec. 31, 2022	$ 2,077,963	$ 13	$ 1,709,835	$ (9,122)	$ 377,237	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		690,811
Vesting of restricted common stock	0
Exercise of stock options (in shares)		455,485
Exercise of stock options	3,395		3,395
Issuance of common stock under employee stock purchase plan (in shares)		114,903
Issuance of common stock under employee stock purchase plan	2,605		2,605
Stock-based compensation	83,044		83,044
Other comprehensive income	7,222			7,222
Contributions from noncontrolling interest owners	100					100
Increase in ownership interest in a subsidiary	(100)		(56)			(44)
Net loss	(499,144)				(499,088)	(56)
Ending balance (in shares) at Sep. 30, 2023		134,497,886
Ending balance at Sep. 30, 2023	1,675,085	$ 13	1,798,823	(1,900)	(121,851)	0
Beginning balance (in shares) at Jun. 30, 2023		134,230,494
Beginning balance at Jun. 30, 2023	1,810,208	$ 13	1,771,536	(2,903)	41,562	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		73,351
Exercise of stock options (in shares)		194,041
Exercise of stock options	343		343
Stock-based compensation	26,944		26,944
Other comprehensive income	1,003			1,003
Net loss	(163,413)				(163,413)
Ending balance (in shares) at Sep. 30, 2023		134,497,886
Ending balance at Sep. 30, 2023	$ 1,675,085	$ 13	1,798,823	(1,900)	(121,851)	0
Beginning balance (in shares) at Dec. 31, 2023	134,781,286	134,781,286
Beginning balance at Dec. 31, 2023	$ 1,590,236	$ 13	1,828,862	(815)	(237,824)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		1,321,120
Vesting of restricted common stock	1	$ 1
Exercise of stock options (in shares)		288,113
Exercise of stock options	701		701
Issuance of common stock under employee stock purchase plan (in shares)		315,831
Issuance of common stock under employee stock purchase plan	2,602		2,602
Stock-based compensation	62,616		62,616
Other comprehensive income	1,942			1,942
Net loss	$ (417,371)				(417,371)
Ending balance (in shares) at Sep. 30, 2024	136,706,350	136,706,350
Ending balance at Sep. 30, 2024	$ 1,240,727	$ 14	1,894,781	1,127	(655,195)	0
Beginning balance (in shares) at Jun. 30, 2024		136,590,097
Beginning balance at Jun. 30, 2024	1,433,670	$ 14	1,878,013	(2,879)	(441,478)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		81,415
Exercise of stock options (in shares)		34,838
Exercise of stock options	71		71
Stock-based compensation	16,697		16,697
Other comprehensive income	4,006			4,006
Net loss	$ (213,717)				(213,717)
Ending balance (in shares) at Sep. 30, 2024	136,706,350	136,706,350
Ending balance at Sep. 30, 2024	$ 1,240,727	$ 14	$ 1,894,781	$ 1,127	$ (655,195)	$ 0